Clinical Trial Update: An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC. [Phase 2]

View source ↗

Summary

Phase 2 umbrella trial investigating molecular pathway-based treatment for patients with metastatic triple-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: TNBC - Triple-Negative Breast Cancer | Phase 2 | Status: UNKNOWN